New drug aims to stop FOP's bone-forming attacks
NCT ID NCT05090891
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 29 times
Summary
This study tests an experimental drug called INCB000928 in people with fibrodysplasia ossificans progressiva (FOP), a rare genetic condition where soft tissues turn into bone. About 98 participants aged 2 and older will receive either the drug or a placebo to see if it reduces new abnormal bone growth. The goal is to slow disease progression and improve quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (FOP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Albert Einstein Israelite Hospital
ACTIVE_NOT_RECRUITINGSão Paulo, 05652-900, Brazil
-
Amsterdam Umc - Vu Medisch Centrum (Vumc)
RECRUITINGAmsterdam, 1081 HV, Netherlands
-
Ap-Hp Hopital Lariboisiere
RECRUITINGParis, 75010, France
-
Beijing Childrens Hospital Capital Medical University
RECRUITINGBeijing, 100045, China
-
Centro de Estudios Reumatologicos
ACTIVE_NOT_RECRUITINGSantiago, 7501126, Chile
-
Children'S Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Childrens Hospital of Fudan University
RECRUITINGShanghai, 201102, China
-
Groote Schuur Hospital Radiation Oncology
ACTIVE_NOT_RECRUITINGCape Town, 07925, South Africa
-
Hopital Necker-Enfants Malades
RECRUITINGParis, 75015, France
-
Hospital Italiano de Buenos Aires
ACTIVE_NOT_RECRUITINGBuenos Aires, CO 1181, Argentina
-
Hospital Universitario Ramon Y Cajal
RECRUITINGMadrid, 28034, Spain
-
Instituto Nacional de Rehabilitacion Luis Guillermo Ibarra
ACTIVE_NOT_RECRUITINGTlalpan, 14389, Mexico
-
Mayo Clinic Rochester
RECRUITINGRochester, Minnesota, 55905, United States
-
Murdoch Children'S Research Institute
ACTIVE_NOT_RECRUITINGParkville, Victoria, 03052, Australia
-
Penn Medicine - Perelman Center For Advanced Medicine
ACTIVE_NOT_RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Policlinico Universitario Agostino Gemelli Universita Cattolica Del Sacro Cuore
ACTIVE_NOT_RECRUITINGRome, 00168, Italy
-
Royal National Orthopaedic Hospital
ACTIVE_NOT_RECRUITINGStanmore, HA7 4LP, United Kingdom
-
Royal North Shore Hospital
COMPLETEDSt Leonards, New South Wales, 02065, Australia
-
Seoul National University Hospital
ACTIVE_NOT_RECRUITINGSeoul, 03080, South Korea
-
Shanghai Childrens Medical Center
RECRUITINGShanghai, 200127, China
-
Starship Childrens Hospital
ACTIVE_NOT_RECRUITINGAuckland, 01023, New Zealand
-
Tongji Hospital of Tongji University
RECRUITINGShanghai, 200065, China
-
Uniklinik Koln
RECRUITINGCologne, 50931, Germany
-
University Health Network Toronto General Hospital
ACTIVE_NOT_RECRUITINGToronto, Ontario, M5G 2N2, Canada
Conditions
Explore the condition pages connected to this study.